Whooping cough, fulminant pertussis, malignant pertussis, severe pertussis, infant, risk factors, bacterial variants, pertactin
SARS-CoV-2, COVID-19 vaccine, Immunological efficacy, Randomized trial, Heterologous vaccination, mRNA vaccine, BNT162b2 vaccine, mRNA-1273 vaccine.